The 3 Medical Device Sales Rep Stages Founders Get Wrong
Key Takeaways
- Most medtech founders jump from founder-led selling directly to a multi-rep team, skipping the one hire that validates whether the process can scale.
- Stage 1 is where the sales playbook gets written, not just where deals get closed.
- Stage 2, the proof-of-process hire, is a single rep with one mission: replicate what the founder did and hit full quota.
- Rep 2-N should only join after Rep 1 has proven the model at full quota for at least one quarter.
- Rick Barnett, founder of Rep-Lite, identified over-hiring at launch as the most consistent commercialization mistake he sees across early-stage medtech companies.
Medical device sales representatives should be added in three distinct stages: founder-led sales first, then a single proof-of-process hire, then team scale.
Most medtech founders skip Stage 2, jumping from "I'm closing deals" to a team of five or ten reps. That sequencing error typically costs 18 months of commercial productivity and an expensive reset.
Watch the full episode on YouTube
Stage 1 Means Founder-Led Sales Is Where the Playbook Gets Written
You don't hire your first medical device sales rep because you're tired of selling. You hire them because you've figured out how to sell, and you need to hand that knowledge off.
Stage 1 is founder-led selling. That means closing deals yourself, building KOL relationships, working through procurement cycles, and learning where your clinical evidence lands and where it doesn't. This phase builds the playbook as much as it builds revenue.
Every conversation is data. Which objection comes up every time? What clinical claim closes the deal? Who are the real economic buyers?
By the end of Stage 1, you should be able to hand a rep a twenty-page playbook and say: here is the sales motion.
If you can't articulate the process yet, you're not ready for Stage 2. What you have is a founder-dependent revenue stream. Before you can scale, you need a medical device go-to-market strategy documented well enough that someone else can follow it.
Stage 2 Is the Proof-of-Process Hire That Most Medtech Founders Skip
This is where I see the sequencing break down. Founders finish Stage 1 with momentum and move straight to a five-rep team. Stage 2 disappears entirely.
Stage 2 is a single hire. One rep. One defined territory. The job: take the founder's playbook and hit full quota.
The rep is not there to expand territory or bring a different approach. The only question Stage 2 answers is whether someone else can follow the process you built.
I interviewed Rick Barnett, founder of Rep-Lite, on an episode about what's broken in medical sales hiring today. He has placed hundreds of medical device sales representatives across early-stage medtech companies, and over-hiring at launch is the most consistent mistake he sees. He said:
"I like the people that say 'how can I make a difference, what do I get to do' versus the other questions like 'how much money can I make' or 'what are the hours.' We're looking for that different mentality."
That mentality is exactly what Stage 2 requires. Because Stage 2 is a proof of concept for your entire commercial function, and you need someone whose instinct is to solve the problem, not manage the territory.
If Rep 1 follows the playbook and hits full quota, you have a repeatable process. You know what good looks like. You have real benchmarks to build comp models around.
If Rep 1 misses quota, you learn that before burning another $500K on three more reps who will also miss it.
Stage 3 Means You Scale What Has Already Been Proven
Rep 2 and beyond only come after one condition is met: Rep 1 has hit full quota for a full quarter.
Not "tracking well." Not "almost there." At quota. For a full quarter.
At that point you have a proven sales motion, real compensation benchmarks, a coaching model, and a rep who can mentor the next hire. That is the foundation for a scalable medical device sales representative organization.
The transition from Stage 2 to Stage 3 also changes the hiring profile entirely. Stage 2 requires someone who can operate in ambiguity and take a rough playbook into the field.
Stage 3 requires someone who can execute a proven process and improve it on the margins. These are different people.
I interviewed Joseph Authement, then VP of Enterprise Commercial at Eko Health, on an episode about going from consumer to enterprise in medtech. He named the personality distinction that separates Stage 2 hires from Stage 3 hires:
"Right up until you're probably in that early majority stage, you need barbarians. And then you start to need builders who are building in better processes."
Hiring builders for Stage 2 is a common mistake. So is hiring barbarians for Stage 3. Both cost time and money that early-stage medtech companies rarely have to spare.
For more on the downstream commercialization decisions that follow this kind of build, see the full medtech commercialization strategy breakdown.
What This Means for Medtech Founders
In my experience working with medtech founders, the 18-month commercial reset is almost always traceable to one decision: scaling before the process was proven.
The problem is structural. A Series A closes. The board pushes for commercial momentum. A head of sales joins and brings on five reps in ninety days. Nobody has a documented playbook.
Quotas are set by guessing at market potential. Territory design is based on geography, not opportunity density.
When the numbers miss in quarter three, everyone assumes the reps are underperforming.
Sometimes they are. More often, the process never existed to begin with.
The companion post covers the medical device sales rep hiring profile in full, including what background to look for, what comp should look like, and what red flags to avoid: What US Surgical Knew About Medical Device Sales Reps That Built a Billion Dollar Training Empire. That post answers who to hire. This post answers when.
The sequence matters as much as the hire itself.
Frequently Asked Questions
When should a medtech company build a medical device sales representative team?
A medtech company should begin building a medical device sales representative team only after the founder has personally closed enough deals to document a repeatable sales process. Stage 1 is founder-led selling.
Stage 2 is a single proof-of-process hire. Stage 3 is team scale, and that only begins after Rep 1 has hit full quota for at least one quarter.
How many medical device sales representatives should a startup hire first?
A medtech startup should hire exactly one medical device sales representative as its first rep.
The first hire is a proof-of-process role with one metric: can this person replicate the founder's sales process at full quota in a defined territory? Only after that is proven should the company hire additional reps.
What is the right structure for a medical device sales organization?
The right structure follows three stages: founder-led selling, a single proof-of-process hire, then scaled hiring. Most early-stage medtech companies skip the proof-of-process stage and begin scaling before the sales motion is validated.
That sequencing mistake typically costs 18 months of commercial productivity and an expensive reset before the team finds its footing.
How do you manage medical device sales representatives in a startup?
In a startup, the first medical device sales representative should be managed against a documented playbook the founder built during the founder-led phase.
Quota benchmarks, territory design, and objection responses should all be defined before the hire starts. Early-stage coaching centers on replication. The rep is executing a documented process, not building a new one.
Listen to Rick Barnett's Full Story
Rick Barnett's full conversation with Omar Khateeb is available on The State of MedTech. Watch on YouTube. Subscribe wherever you listen to podcasts.
About Rick Barnett
Rick Barnett is the founder of Rep-Lite, a fractional and permanent medical device sales staffing firm. He has placed hundreds of medical device sales representatives across early-stage and growth-stage medtech companies and has become one of the most-cited voices on commercial hiring in the medtech industry.
About the Author
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.
He works with medtech founders and commercial leaders on market engineering, commercialisation strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.